Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 5634

Sort by

Sort Order Select

Journal Articles

Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia

Nicholas J. Short, Hagop Kantarjian, Nitin Jain, Tapan M. Kadia, Jayastu Senapati, Fadi G. Haddad, Manuel M. Maroun, Koji Sasaki, Lianchun Xiao, Xuelin Huang, Omer Karrar, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Elias Jabbour

Blood Adv (2026) 10 (1): 25–28.

https://doi.org/10.1182/bloodadvances.2025016565

Published: 2026

Includes: Supplemental data

Journal Articles

Safety and efficacy of daratumumab in immune thrombocytopenia

Galina Tsykunova, Pål Andre Holme, Hoa Thi Tuyet Tran, Henrik Frederiksen, Eirik Tjønnfjord, Ludvig A. Munthe, Elsa Drivet, Hassen Kared, Ingvild Hausberg Sørvoll, Maria Therese Ahlen, Matthiéu Mahévas, Marc Michel, James Bussel, David J. Kuter, Tor Henrik Anderson Tvedt, Waleed Ghanima

Blood Adv (2026) 10 (1): 143–154.

https://doi.org/10.1182/bloodadvances.2025017279

Published: 2026

Includes: Supplemental data

Journal Articles

The ASH Research Collaborative Sickle Cell Disease Research Network: past, present, and future

Fuad El Rassi, Biree Andemariam, Abdullah Kutlar, Betty S. Pace, Aliza Fink, Kathleen Torres, Christopher Dowd, Charles S. Abrams

Blood Adv (2026) 10 (1): 48–57.

https://doi.org/10.1182/bloodadvances.2025016394

Published: 2026

Journal Articles

Artificial intelligence accelerates the interpretation of measurable residual B lymphoblastic leukemia by flow cytometry

Jansen N. Seheult, Gregory E. Otteson, Michael M. Timm, Matthew J. Weybright, Min Shi, Horatiu Olteanu, Dragan Jevremovic, Chuan Chen, April Chiu, Pedro Horna

Blood Adv (2026) 10 (1): 58–69.

https://doi.org/10.1182/bloodadvances.2025016126

Published: 2026

Includes: Supplemental data

Journal Articles

Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel

Blood Adv (2026) 10 (1): 106–110.

https://doi.org/10.1182/bloodadvances.2025017012

Published: 2026

Journal Articles

Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group

Marion Aymard, Morgane Cheminant, Roch Houot, Anne Cuozzo, Elodie Gat, Catherine Thieblemont, Laure Ricard, Louise Roulin, Krimo Bouabdallah, Violaine Safar, Stéphanie Guidez, Amandine Fayard, Gabriel Brisou, Loic Ysebaert, Olivier Hermine, Benoît Tessoulin, Charles Herbaux, Steven Le Gouill, Clémentine Sarkozy

Blood Adv (2026) 10 (1): 75–82.

https://doi.org/10.1182/bloodadvances.2025017234

Published: 2026

Includes: Supplemental data

Journal Articles

MicroRNA-223-3p is a determinant of platelet procoagulant activity

Julia Charlon-Gay, Séverine Nolli, Sylvie Dunoyer-Geindre, Paulina Ciepla, Jean-Luc Reny, Pierre Fontana

Blood Adv (2026) 10 (1): 83–94.

https://doi.org/10.1182/bloodadvances.2024015290

Published: 2026

Includes: Supplemental data

Journal Articles

Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia

Bruno Fattizzo, Anna Zaninoni, Giacinto Luca Pedone, Marta Bortolotti, Francesco Passamonti, Wilma Barcellini

Blood Adv (2026) 10 (1): 124–131.

https://doi.org/10.1182/bloodadvances.2025017722

Published: 2026

Journal Articles

Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection

Parvathi Sudha, Phillip Pham, Wen Niu, Enze Liu, Lin Wang, Gillian Truong, Cameron Ligocki, Ramzi Al-Azzawi, Malini Surapenini, Steven M. Bray, Francesco Vetrini, Magdalena Czader, Marwan K. Tayeh, Kelvin Lee, Rafat Abonour, Attaya Suvannasankha, Brian A. Walker

Blood Adv (2026) 10 (1): 95–105.

https://doi.org/10.1182/bloodadvances.2025017721

Published: 2026

Includes: Supplemental data

Journal Articles

MRD assessment by flow cytometry in B-ALL made easier

Joseph DiGiuseppe, Sindhu Cherian

Blood Adv (2026) 10 (1): 121–123.

https://doi.org/10.1182/bloodadvances.2025018222

Published: 2026

Journal Articles

Pyruvate kinase M2 promotes venous thrombosis by enhancing SNAP23-mediated platelet exocytosis and consequent NETosis

Manasa K. Nayak, Gagan D. Flora, Ivan Budnik, Tarun Barbhuyan, Rakesh B. Patel, Madankumar Ghatge, Mariia Kumskova, Aditi Jain, Neelam Chauhan, Jitendra Kumar, Megan Jewell, Santosh Kumar, Steven R. Lentz, Keith B. Neeves, Anil K. Chauhan

Blood Adv (2026) 10 (1): 132–142.

https://doi.org/10.1182/bloodadvances.2025017414

Published: 2026

Includes: Supplemental data

Journal Articles

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism

Sirui Ma, Yu-Cheng Chang, Cho-Han Chiang, Junmin Song, Yu-Che Lee, Ko-Yun Chang, Robert A. Redd, Thita Chiasakul, Ellen P. McCarthy, Jeffrey I. Zwicker, Rushad Patell, Avi Leader

Blood Adv (2026) 10 (1): 14–24.

https://doi.org/10.1182/bloodadvances.2025017523

Published: 2026

Includes: Supplemental data

Journal Articles

BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant

Dimana Dimitrova, Elisabetta Xue, Mustafa A. Hyder, Hyoyoung Choo-Wosoba, Kamil Rechache, Francis A. Flomerfelt, Sanchita Das, Christi McKeown, Alison Cusmano, Ruby Sabina, Jennifer A. Kanakry, Christopher G. Kanakry

Blood Adv (2026) 10 (1): 1–13.

https://doi.org/10.1182/bloodadvances.2025016589

Published: 2026

Includes: Supplemental data

Journal Articles

Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq

Yifan Yin, Shinya Rai, Aixiang Jiang, Alexander Xu, Luke O’Brien, Adèle Telenius, Jan Delabie, Lauren Chong, Stacy Hung, Akil Merchant, David W. Scott, Kerry J. Savage, Tomohiro Aoki, Christian Steidl

Blood Adv (2026) 10 (1): 29–38.

https://doi.org/10.1182/bloodadvances.2025017107

Published: 2026

Includes: Supplemental data

Journal Articles

Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1

Kelly E. Faulk, John A. Kairalla, Emily Hibbitts, Janel Long-Boyle, Meenakshi Devidas, Amanda August, Lia Gore, Elizabeth Raetz, Stephen P. Hunger, Mignon L. Loh, David T. Teachey, Patrick Brown, Erin H. Breese, Rishi S. Kotecha, Erin Guest

Blood Adv (2026) 10 (1): 70–74.

https://doi.org/10.1182/bloodadvances.2025017013

Published: 2026

Includes: Supplemental data

Journal Articles

Danazol treatment for telomere biology disorders: long-term results of a phase 1/2 study

Nicholas C. Lee, Fernanda Gutierrez-Rodrigues, Ruba Shalhoub, Tania Machado, Jennifer Lotter, Lemlem Alemu, Diego Quinones Raffo, Subrata Paul, Sachiko Kajigaya, Geraldine Aubert, Colin O. Wu, Neal S. Young, Bhavisha A. Patel, Emma M. Groarke

Blood Adv (2026) 10 (1): 208–212.

https://doi.org/10.1182/bloodadvances.2025017860

Published: 2026

Includes: Supplemental data

Journal Articles

Targeting the lectin pathway in TA-TMA

Sonata Jodele

Blood Adv (2026) 10 (1): 181–182.

https://doi.org/10.1182/bloodadvances.2025018551

Published: 2026

Journal Articles

Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years

Anna C. Ferreira, Debjani Dutta, Courtney M. Rowan, Jamie Renbarger, Kenneth R. Cooke, Paul A. Carpenter, Robert Krance, Christine Duncan, C. Russell Y. Cruz, David Jacobsohn, Catherine M. Bollard, Elizabeth Hill, Sophie Paczesny

Blood Adv (2026) 10 (1): 168–180.

https://doi.org/10.1182/bloodadvances.2025016624

Published: 2026

Includes: Supplemental data

Journal Articles

Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma

Keri Toner, Lindsay A. Renfro, Hema Dave, Gloria Pezzella, Qinglin Pei, Lisa Giulino-Roth, Terzah Horton, Frank G. Keller, Kara M. Kelly, Sharon M. Castellino, Catherine M. Bollard

Blood Adv (2026) 10 (1): 183–191.

https://doi.org/10.1182/bloodadvances.2025016797

Published: 2026

Includes: Supplemental data

Journal Articles

Short- and long-term effects of transfusion in β-thalassemia: a longitudinal study of transfusion efficiency factors

Blood Adv (2026) 10 (1): 192–207.

https://doi.org/10.1182/bloodadvances.2025017090

Published: 2026

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia

Safety and efficacy of daratumumab in immune thrombocytopenia

The ASH Research Collaborative Sickle Cell Disease Research Network: past, present, and future

Artificial intelligence accelerates the interpretation of measurable residual B lymphoblastic leukemia by flow cytometry

Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel

Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group

MicroRNA-223-3p is a determinant of platelet procoagulant activity

Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia

Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection

MRD assessment by flow cytometry in B-ALL made easier

Pyruvate kinase M2 promotes venous thrombosis by enhancing SNAP23-mediated platelet exocytosis and consequent NETosis

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism

BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant

Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq

Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1

Danazol treatment for telomere biology disorders: long-term results of a phase 1/2 study

Targeting the lectin pathway in TA-TMA

Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years

Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma

Short- and long-term effects of transfusion in β-thalassemia: a longitudinal study of transfusion efficiency factors

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only